Literature DB >> 23241902

TLR signaling in B-cell development and activation.

Zhaolin Hua1, Baidong Hou.   

Abstract

Expression of Toll-like receptors (TLRs) in B cells provides a cell-intrinsic mechanism for innate signals regulating adaptive immune responses. In combination with other signaling pathways in B cells, including through the B-cell receptor (BCR), TLR signaling plays multiple roles in B-cell differentiation and activation. The outcome of TLR signaling in B cells is largely context-dependent, which partly explains discrepancies among in vitro and in vivo studies, or studies using different immunogens. We focus on recent findings on how B-cell-intrinsic TLR signaling regulates antibody responses, including germinal center formation and autoantibody production in autoimmune disease models. In addition, TLR signaling also acts on the precursors of B cells, which could influence the immune response of animals by shaping the composition of the immune system. With TLR signaling modulating immune responses at these different levels, much more needs to be understood before we can depict the complete functions of innate signaling in host defense.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23241902      PMCID: PMC4003046          DOI: 10.1038/cmi.2012.61

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  37 in total

1.  Control of B-cell responses by Toll-like receptors.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

2.  Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

Authors:  Scott A Halperin; Simon Dobson; Shelly McNeil; Joanne M Langley; Bruce Smith; Robyn McCall-Sani; Dan Levitt; Gary Van Nest; Daniel Gennevois; Joseph J Eiden
Journal:  Vaccine       Date:  2005-09-12       Impact factor: 3.641

3.  Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment.

Authors:  Yoshinori Nagai; Karla P Garrett; Shoichiro Ohta; Uleng Bahrun; Taku Kouro; Shizuo Akira; Kiyoshi Takatsu; Paul W Kincade
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

4.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

5.  Evolution of autoantibody responses via somatic hypermutation outside of germinal centers.

Authors:  Jacqueline William; Chad Euler; Sean Christensen; Mark J Shlomchik
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

6.  Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice.

Authors:  S Seo ; J Buckler; J Erikson
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

7.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

8.  IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients.

Authors:  Sandra Weller; Mélanie Bonnet; Héloïse Delagreverie; Laura Israel; Maya Chrabieh; László Maródi; Carlos Rodriguez-Gallego; Ben-Zion Garty; Chaim Roifman; Andrew C Issekutz; Simona Eva Zitnik; Cyrille Hoarau; Yildiz Camcioglu; Júlia Vasconcelos; Carlos Rodrigo; Peter D Arkwright; Andrea Cerutti; Eric Meffre; Shen-Ying Zhang; Alexandre Alcais; Anne Puel; Jean-Laurent Casanova; Capucine Picard; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

Review 9.  Toll-like receptors in systemic autoimmune disease.

Authors:  Ann Marshak-Rothstein
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

10.  TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.

Authors:  Marc Ehlers; Hidehiro Fukuyama; Tracy L McGaha; Alan Aderem; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2006-02-21       Impact factor: 14.307

View more
  81 in total

1.  Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus.

Authors:  Kristian Taipale; Ilkka Liikanen; Juuso Juhila; Riku Turkki; Siri Tähtinen; Matti Kankainen; Lotta Vassilev; Ari Ristimäki; Anniina Koski; Anna Kanerva; Iulia Diaconu; Vincenzo Cerullo; Markus Vähä-Koskela; Minna Oksanen; Nina Linder; Timo Joensuu; Johan Lundin; Akseli Hemminki
Journal:  Mol Ther       Date:  2015-08-27       Impact factor: 11.454

Review 2.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397

3.  Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Authors:  Mariann Kremlitzka; Bernadett Mácsik-Valent; Anna Erdei
Journal:  Cell Mol Life Sci       Date:  2014-12-28       Impact factor: 9.261

Review 4.  mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Authors:  Giulietta Maruggi; Cuiling Zhang; Junwei Li; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-02-07       Impact factor: 11.454

Review 5.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

6.  Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury.

Authors:  Luigi Adamo; Lora J Staloch; Cibele Rocha-Resende; Scot J Matkovich; Wenlong Jiang; Geetika Bajpai; Carla J Weinheimer; Attila Kovacs; Joel D Schilling; Philip M Barger; Deepta Bhattacharya; Douglas L Mann
Journal:  JCI Insight       Date:  2018-06-07

7.  Frontiers in B-cell immunology.

Authors:  Liwei Lu
Journal:  Cell Mol Immunol       Date:  2012-12-24       Impact factor: 11.530

8.  Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia.

Authors:  Hiroyoshi Doi; Eiichi Hayashi; Jun Arai; Masayuki Tojo; Kenichi Morikawa; Junichi Eguchi; Takayoshi Ito; Tatsuya Kanto; David E Kaplan; Hitoshi Yoshida
Journal:  J Gastroenterol Hepatol       Date:  2018-02-10       Impact factor: 4.029

Review 9.  The Tao of myeloma.

Authors:  Lawrence H Boise; Jonathan L Kaufman; Nizar J Bahlis; Sagar Lonial; Kelvin P Lee
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 10.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.